Earl Martin Douglas
SVP, General Counsel · Allogene Therapeutics, Inc.
- 2026
- Aug 25, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Earl Martin Douglas files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David D. Chang - $289K in ALLO purchases and sales in the last 12 months
- Zachary Roberts - $104K in ALLO purchases and sales in the last 12 months
- Geoffrey M. Parker - $88K in ALLO purchases and sales in the last 12 months
- Benjamin Machinas Beneski - $52K in ALLO purchases and sales in the last 12 months
- Annie Yoshiyama - $29K in ALLO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Earl Martin Douglas?
Earl Martin Douglas is a corporate insider, tracked as SVP, General Counsel of Allogene Therapeutics, Inc. (ALLO). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Earl Martin Douglas submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Earl Martin Douglas been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($103K) across all tracked filings.
